GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Varian Medical Systems Inc (NYSE:VAR) » Definitions » Beneish M-Score

Varian Medical Systems (Varian Medical Systems) Beneish M-Score : -2.66 (As of Apr. 26, 2024)


View and export this data going back to 1976. Start your Free Trial

What is Varian Medical Systems Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.66 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Varian Medical Systems's Beneish M-Score or its related term are showing as below:

VAR' s Beneish M-Score Range Over the Past 10 Years
Min: -3.07   Med: -2.5   Max: 0.74
Current: -2.66

During the past 13 years, the highest Beneish M-Score of Varian Medical Systems was 0.74. The lowest was -3.07. And the median was -2.50.


Varian Medical Systems Beneish M-Score Historical Data

The historical data trend for Varian Medical Systems's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Varian Medical Systems Beneish M-Score Chart

Varian Medical Systems Annual Data
Trend Sep11 Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.45 -2.49 -2.69 -2.27 -2.68

Varian Medical Systems Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.29 -2.47 -2.61 -2.68 -2.66

Competitive Comparison of Varian Medical Systems's Beneish M-Score

For the Medical Instruments & Supplies subindustry, Varian Medical Systems's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Varian Medical Systems's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Varian Medical Systems's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Varian Medical Systems's Beneish M-Score falls into.



Varian Medical Systems Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Varian Medical Systems for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0134+0.528 * 0.9766+0.404 * 1.0264+0.892 * 0.9412+0.115 * 1.0499
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0588+4.679 * -0.039504-0.327 * 0.8485
=-2.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec20) TTM:Last Year (Dec19) TTM:
Total Receivables was $1,029 Mil.
Revenue was 778.8 + 850.5 + 694.3 + 794.5 = $3,118 Mil.
Gross Profit was 359 + 374.7 + 298.5 + 337.2 = $1,369 Mil.
Total Current Assets was $2,641 Mil.
Total Assets was $4,526 Mil.
Property, Plant and Equipment(Net PPE) was $466 Mil.
Depreciation, Depletion and Amortization(DDA) was $100 Mil.
Selling, General, & Admin. Expense(SGA) was $657 Mil.
Total Current Liabilities was $1,745 Mil.
Long-Term Debt & Capital Lease Obligation was $102 Mil.
Net Income was 96.5 + 76.6 + 61.2 + 43.2 = $278 Mil.
Non Operating Income was -2 + -14.5 + -3.2 + -36.9 = $-57 Mil.
Cash Flow from Operations was 141.4 + 266.6 + 83 + 21.9 = $513 Mil.
Total Receivables was $1,079 Mil.
Revenue was 828.9 + 878.9 + 825.8 + 779.4 = $3,313 Mil.
Gross Profit was 366.8 + 384.6 + 351.4 + 318.2 = $1,421 Mil.
Total Current Assets was $2,647 Mil.
Total Assets was $4,451 Mil.
Property, Plant and Equipment(Net PPE) was $444 Mil.
Depreciation, Depletion and Amortization(DDA) was $101 Mil.
Selling, General, & Admin. Expense(SGA) was $659 Mil.
Total Current Liabilities was $2,046 Mil.
Long-Term Debt & Capital Lease Obligation was $94 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1029.3 / 3118.1) / (1079.2 / 3313)
=0.330105 / 0.325747
=1.0134

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1421 / 3313) / (1369.4 / 3118.1)
=0.428916 / 0.439178
=0.9766

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (2641.3 + 466) / 4526.1) / (1 - (2647 + 444.4) / 4450.7)
=0.313471 / 0.305413
=1.0264

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=3118.1 / 3313
=0.9412

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(100.7 / (100.7 + 444.4)) / (99.5 / (99.5 + 466))
=0.184737 / 0.17595
=1.0499

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(656.7 / 3118.1) / (659 / 3313)
=0.210609 / 0.198913
=1.0588

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((101.7 + 1744.9) / 4526.1) / ((93.7 + 2046.4) / 4450.7)
=0.407989 / 0.480846
=0.8485

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(277.5 - -56.6 - 512.9) / 4526.1
=-0.039504

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Varian Medical Systems has a M-score of -2.66 suggests that the company is unlikely to be a manipulator.


Varian Medical Systems Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Varian Medical Systems's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Varian Medical Systems (Varian Medical Systems) Business Description

Traded in Other Exchanges
N/A
Address
3100 Hansen Way, Palo Alto, CA, USA, 94304-1038
Varian Medical Systems designs, manufactures, and sells radiation technology for use in two business segments: oncology systems and proton therapy. The Americas account for the largest portion of revenue (47%), followed by Europe, the Middle East, and Africa (33%) and Asia-Pacific (19%).
Executives
Jesse Michael Bruff officer: SVP Finance, CFO 3100 HANSEN WAY, PALO ALTO CA 94304
Magnus Momsen officer: SVP, CAO, Corporate Controller VARIAN MEDICAL SYSTEMS INC. 3100 HANSEN WAY MAIL STOP E327 PALO ALTO CA 94304
Dow R Wilson director, officer: President and CEO VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
Kolleen T Kennedy officer: Pres. Proton Solutions, CGO VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
Christopher A. Toth officer: SVP and Pres. Oncology Systems 1252 COOLIDGE AVE., SAN JOSE CA 95125
Michael Damon Hutchinson officer: SVP,Chief Legal Officer, Secy 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Jean Luc Butel director ONE BAXTER PARKWAY, DEERFIELD IL 60015
John W Kuo officer: SVP, Gen Counsel and Secretary VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
Judy Bruner director C/O SANDISK CORPORATION, 601 MCCARTHY BLVD., MILPITAS CA 95035
Beau Michelle Le director 800 N. MICHIGAN AVENUE #3703 CHICAGO IL 60611
Anat Ashkenazi director LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Jeffrey R. Balser director 3657 RICHLAND AVE., NASHVILLE TN 37205
Regina E Dugan director VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
David J Illingworth director 3100 HANSEN WAY PALO ALTO CA 94304
R Andrew Eckert director THREE RAVINIA DRIVE, ATLANTA GA 30346

Varian Medical Systems (Varian Medical Systems) Headlines

From GuruFocus